Pharma & Biotech News #PharmaBuzz

Weekly News Recap #Phispers

Gilead buys Arcellx for US$ 7.8 billion; FDA approves Vanda's antipsychotic pill for bipolar disorder, schizophrenia

In this week’s news, Gilead Sciences has entered into an agreement to acquire its cancer therapy partner Arcellx for US$ ...

Impressions : 421

FDA agrees to review Moderna's amended mRNA-based flu vaccine application; Lilly builds orforglipron stock ahead of approval

Last week, the US Food and Drug Administration (FDA) had said it will not review Moderna’s application for its experiment...

Impressions : 1453

FDA refuses to review Moderna's mRNA-based flu vaccine application; Lilly buys Orna for up to US$ 2.4 billion

The US Food and Drug Administration (FDA) has said it will not review Moderna’s application for its experimental influenz...

Impressions : 1474

Lilly expects 25% growth, Novo sees its sales drop in 2026; Amgen turns down FDA request to withdraw rare disease drug

In this week’s Phispers, we bring you the split story of two GLP-1 drugmakers — Eli Lilly and Novo Nordisk. While L...

Impressions : 1029